StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) shareholders

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
36.9%
2M of 5M shares
Institutional holders
37
4 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $202.35K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
AMH Equity LLC
Joint filing with Leviticus Partners LP (9.20%)
4,047,5359.20%13G (passive) amendmentAug 6, 2025
Weber Capital Management, LLC3,200,3807.26%13G (passive) amendmentMar 31, 2025
William Snider
Joint filing with BroadOak Capital Partners, LLC (15.57%), BroadOak Income Fund, L.P. (15.34%)
846,00015.97%13D (active)Dec 17, 2025
Leviticus Partners LP235,0005.20%13G (passive) amendmentSep 14, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of HBIOValueChange% of portfolio
Weber Capital Management LLC /Adv310,8616.83%$1.91M−9,1761.63%
Meros Investment Management, LP182,9924.02%$1.13M+64,4700.36%
Acadian Asset Management LLC179,6143.95%$1.10M–0.00%
Vanguard Capital Management LLC169,6253.73%$1.04M+6,3120.00%
Nano Cap New Millennium Growth Fund L P143,0823.14%$879.95K+25,5820.68%
Corsair Capital Management, L.P.122,8102.70%$755.28K−2,0000.09%
Two Sigma Investments, LP114,5452.52%$704.45K+4280.00%
Renaissance Technologies LLC99,3272.18%$610.86K−2,1000.00%
BlackRock, Inc.61,8341.36%$380.28K−3920.00%
Geode Capital Management, LLC47,5551.04%$292.53K−11,9560.00%
Mink Brook Asset Management LLC33,3690.73%$205.22KNew0.09%
Millennium Management LLC32,6200.72%$200.61K−13,7120.00%
Vanguard Fiduciary Trust Co27,7300.61%$170.54K–0.00%
Essex Investment Management Co LLC26,9730.59%$165.88K−480.02%
Williams & Novak, LLC20,9490.46%$128.84K−6,1030.09%
UBS Group AG17,5810.39%$108.12K+9,1760.00%
RBF Capital, LLC16,0000.35%$98.40K–0.00%
State Street Corp14,9320.33%$91.83K–0.00%
Jane Street Group, LLC13,9820.31%$85.99K−9,8480.00%
Citadel Advisors LLC13,2510.29%$81.49KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026372M36.9%4 / 516 / 20M0M
Q1 2026372M34.8%3 / 1018 / 290M0M
Q4 2025642M38.7%13 / 2016 / 81M0M
Q3 2025612M36.5%5 / 930 / 130M0M
Q2 2025692M41.6%14 / 1927 / 370M1M
Q1 2025923M56.3%10 / 2237 / 120M1M
Q4 2024963M68.2%16 / 3625 / 140M0M
Q3 2024953M68.8%14 / 3227 / 180M0M
Q2 20241003M69.9%21 / 4225 / 110M0M
Q1 2024903M71.8%8 / 2839 / 100M0M
Q4 2023933M73.2%7 / 3428 / 80M0M
Q3 2023943M72.3%8 / 4027 / 140M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

15 funds held HBIO in Q2 2026, 72% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of HBIOValue% of fundAs of
Vanguard Total Stock Market Index Fund123,4702.71%$759.34K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund42,0430.92%$258.56K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund27,7690.61%$163.28K0.00%May 31, 2026
Acuitas US Microcap Fund13,3800.29%$82.29K0.07%Jun 30, 2026
Fidelity Total Market Index Fund7,0170.15%$41.26K0.00%May 31, 2026
Fidelity Series Total Market Index Fund5,9460.13%$34.96K0.00%May 31, 2026
Vanguard Balanced Index Fund4,1120.09%$25.29K0.00%Jun 30, 2026
Gabelli Global Mini Mites Fund4,0000.09%$24.60K0.09%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund2,9360.06%$17.26K0.00%May 31, 2026
Dimensional US Sustainability Core 1 ETF1,9020.04%$11.60K0.00%Jul 31, 2026
Dimensional U.S. Small Cap ETF1,3660.03%$8.33K0.00%Jul 31, 2026
U.S. Vector Equity Portfolio1,2290.03%$7.50K0.00%Jul 31, 2026
Dimensional U.S. Core Equity 2 ETF1,0290.02%$6.28K0.00%Jul 31, 2026
Dimensional US Core Equity 1 ETF9280.02%$5.66K0.00%Jul 31, 2026
Blackstone Alternative Multi-Strategy Fund6830.02%$4.20K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
John D. DukeChief Executive Officer, Director180,0003.95%Mar 23, 2026
Mark T. FrostChief Financial Officer17,5000.38%Apr 1, 2026
Jennifer CoteChief Financial Officer159,0193.49%Mar 21, 2025
Katherine A. EadeDirector58,6691.29%Jun 12, 2026
Stephen J. DenelskyDirector37,5560.82%Jun 11, 2026
William SniderDirector48,5561.07%Jun 11, 2026
Robert E. GagnonDirector27,5560.61%Jun 11, 2026
Seth Benjamin BensonDirector27,5560.61%Jun 11, 2026
James W. GreenDirector4,062,78289.25%Aug 19, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Katherine A. Eade
Director
Jun 9, 2026Award+16,556––58,669
Stephen J. Denelsky
Director
Jun 9, 2026Award+16,556––37,556
William Snider
Director
Jun 9, 2026Award+16,556––48,556
Seth Benjamin Benson
Director
Jun 9, 2026Award+16,556––27,556
Robert E. Gagnon
Director
Jun 9, 2026Award+16,556––27,556
Mark T. Frost
Chief Financial Officer
Mar 20, 2026Award+30,000––47,500
John D. Duke
Chief Executive Officer, Director
Mar 20, 2026Award+75,000––180,000
William Snider
Director
Mar 17, 2026Buy+8,475$4.85$41.10K32,000
Stephen J. Denelsky
Director
Mar 17, 2026Buy+10,000$4.87$48.70K21,000
Mark T. Frost
Chief Financial Officer
Mar 16, 2026Buy+5,000$5.00$25.00K17,500
William Snider
Director
Mar 16, 2026Buy+12,525$4.99$62.50K23,525
John D. Duke
Chief Executive Officer, Director
Mar 16, 2026Buy+5,000$5.01$25.05K105,000
William Snider
Director
Dec 17, 2025Award+110,000––110,000
Stephen J. Denelsky
Director
Sep 5, 2025Award+110,000––110,000
James W. Green
Director
Aug 15, 2025Tax withholding−11,540$0.53$6.12K2,631,968
James W. Green
Director
Aug 15, 2025Returned to company−119,332––2,643,508
James W. Green
Director
Aug 15, 2025Tax withholding−33,200$0.53$17.60K2,762,840
James W. Green
Director
Aug 15, 2025Returned to company−49,048––2,796,040
James W. Green
Director
Aug 15, 2025Returned to company−66,036––2,565,905
James W. Green
Director
Aug 15, 2025Returned to company−113,366––2,452,566
John D. Duke
Chief Executive Officer, Director
Aug 8, 2025Award+500,000––1,000,000
John D. Duke
Chief Executive Officer, Director
Aug 8, 2025Award+500,000––500,000
Seth Benjamin Benson
Director
Jul 16, 2025Award+110,000––110,000
Robert E. Gagnon
Director
Jul 16, 2025Award+110,000––110,000
Katherine A. Eade
Director
Jul 16, 2025Award+110,000––421,126
Mark T. Frost
Interim CFO
May 12, 2025Award+100,000––125,000
Jennifer Cote
Chief Financial Officer
Mar 19, 2025Tax withholding−5,687$0.69$3.92K159,019
James W. Green
Chief Executive Officer, Director
Mar 19, 2025Tax withholding−38,413$0.69$26.50K2,845,088
James W. Green
Chief Executive Officer, Director
Dec 31, 2024Returned to company−145,365––2,883,501
James W. Green
Chief Executive Officer, Director
Dec 29, 2024Tax withholding−25,310$1.98$50.11K3,028,866
James W. Green
Chief Executive Officer, Director
Dec 29, 2024Tax withholding−56,915$1.98$112.69K3,054,176
Jennifer Cote
Chief Financial Officer
Dec 29, 2024Tax withholding−4,731$1.98$9.37K164,007
Jennifer Cote
Chief Financial Officer
Dec 29, 2024Tax withholding−3,797$1.98$7.52K160,210
James W. Green
Chief Executive Officer, Director
Jun 13, 2024Buy+10,000$2.91$29.10K3,111,091
James W. Green
Chief Executive Officer, Director
Jun 6, 2024Buy+20,000$3.07$61.40K3,101,091
Katherine A. Eade
Director
May 21, 2024Award+45,872––311,126
Thomas W. Loewald
Director
May 21, 2024Award+45,872––295,311
Alan I. Edrick
Director
May 21, 2024Award+45,872––273,911
Bertrand Loy
Director
May 21, 2024Award+56,575––56,575
Jennifer Cote
Chief Financial Officer
Mar 6, 2024Tax withholding−9,920$4.11$40.77K168,738
James W. Green
Chief Executive Officer, Director
Mar 5, 2024Award+214,797––2,866,294
James W. Green
Chief Executive Officer, Director
Mar 5, 2024Award+214,797––3,081,091
Jennifer Cote
Chief Financial Officer
Mar 5, 2024Award+35,800––142,858
Jennifer Cote
Chief Financial Officer
Mar 5, 2024Award+35,800––178,658
James W. Green
Chief Executive Officer, Director
Dec 31, 2023Tax withholding−82,790$5.35$442.93K2,651,497
Jennifer Cote
Chief Financial Officer, Director
Dec 29, 2023Tax withholding−3,279$5.35$17.54K109,689
Jennifer Cote
Chief Financial Officer, Director
Dec 29, 2023Tax withholding−2,631$5.35$14.08K107,058
James W. Green
Chief Executive Officer, Director
Dec 29, 2023Tax withholding−52,206$5.35$279.30K2,734,287
James W. Green
Chief Executive Officer, Director
Dec 29, 2023Tax withholding−24,187$5.35$129.40K2,838,492
James W. Green
Chief Executive Officer, Director
Dec 29, 2023Tax withholding−28,783$5.35$153.99K2,809,709
James W. Green
Chief Executive Officer, Director
Dec 29, 2023Tax withholding−23,216$5.35$124.21K2,786,493
James W. Green
Chief Executive Officer, Director
Aug 17, 2023Buy+25,000$4.38$109.50K2,862,679
James W. Green
Chief Executive Officer, Director
Jun 11, 2023Tax withholding−48,373$5.46$264.12K2,837,679
Alan I. Edrick
Director
May 22, 2023Award+25,554––228,039
Thomas W. Loewald
Director
May 22, 2023Award+25,554––249,439
Katherine A. Eade
Director
May 22, 2023Award+25,554––265,254
Bertrand Loy
Director
May 22, 2023Award+31,516––79,009
Alan I. Edrick
Director
Mar 15, 2023Buy+16,192$2.62$42.42K202,485
James W. Green
Chief Executive Officer, Director
Mar 15, 2023Buy+20,000$2.60$52.00K2,886,052
Alan I. Edrick
Director
Mar 14, 2023Buy+13,808$2.67$36.87K186,293

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
1.46%
0M shares short
Days to cover
3.5
At 0M shares a day
Change since last report
+32.5%
From 0M shares
Short volume, 20 days
46.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Harvard Bioscience's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?